Glenmark Life Sciences (GLS.NSE) Q3 2024 Earnings

25JulConfirmed
Q1 2024
Q3 2024
8
9.55
11.1
12.64

Details

Expected EPS
9.789892769475
Actual EPS
8.93641493829
Surprise EPS
-0.85
Surprise Percent
+8.72%

Description

Glenmark Life Sciences (GLS.NSE) has reported earnings of 8.93641493829 per share for Q3 2024.

0 Comments

Share your thoughts